---
input_text: Human glia can both induce and rescue aspects of disease phenotype in
  Huntington disease. The causal contribution of glial pathology to Huntington disease
  (HD) has not been heavily explored. To define the contribution of glia to HD, we
  established human HD glial chimeras by neonatally engrafting immunodeficient mice
  with mutant huntingtin (mHTT)-expressing human glial progenitor cells (hGPCs), derived
  from either human embryonic stem cells or mHTT-transduced fetal hGPCs. Here we show
  that mHTT glia can impart disease phenotype to normal mice, since mice engrafted
  intrastriatally with mHTT hGPCs exhibit worse motor performance than controls, and
  striatal neurons in mHTT glial chimeras are hyperexcitable. Conversely, normal glia
  can ameliorate disease phenotype in transgenic HD mice, as striatal transplantation
  of normal glia rescues aspects of electrophysiological and behavioural phenotype,
  restores interstitial potassium homeostasis, slows disease progression and extends
  survival in R6/2 HD mice. These observations suggest a causal role for glia in HD,
  and further suggest a cell-based strategy for disease amelioration in this disorder.
raw_completion_output: |-
  primary_disease: Huntington disease

  medical_actions: Engrafting immune-deficient mice with mutant huntingtin-expressing human glial progenitor cells; Striatal transplantation of normal glia

  symptoms: Worse motor performance; Hyperexcitability of striatal neurons; Disturbed interstitial potassium homeostasis

  chemicals: 

  action_annotation_relationships: Engrafting immune-deficient mice with mutant huntingtin-expressing human glial progenitor cells INDUCES worse motor performance IN Huntington disease; Engrafting immune-deficient mice with mutant huntingtin-expressing human glial progenitor cells INDUCES hyperexcitability of striatal neurons IN Huntington disease; Striatal transplantation of normal glia RESCUES worse motor performance IN Huntington disease; Striatal transplantation of normal glia RESCUES hyperexcitability of striatal neurons IN Huntington disease; Striatal transplantation of normal glia RESTORES disturbed interstitial potassium homeostasis IN Huntington disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Striatal transplantation of normal glia RESTORES disturbed interstitial potassium homeostasis IN Huntington disease

  ===

extracted_object:
  primary_disease: MONDO:0007739
  medical_actions:
    - Engrafting immune-deficient mice with mutant huntingtin-expressing human glial
      progenitor cells
    - Striatal transplantation of normal glia
  symptoms:
    - Worse motor performance
    - Hyperexcitability of striatal neurons
    - Disturbed interstitial potassium homeostasis
  action_annotation_relationships:
    - subject: Engrafting immune-deficient mice with mutant huntingtin-expressing
        human glial progenitor cells
      predicate: INDUCES
      object: worse motor performance
      qualifier: MONDO:0007739
    - subject: <Engrafting immune-deficient mice>
      predicate: <INDUCES>
      object: <hyperexcitability of striatal neurons>
      qualifier: <Huntington disease>
      subject_extension: <mutant huntingtin-expressing human glial progenitor cells>
    - subject: Striatal transplantation
      predicate: RESCUES
      object: worse motor performance
      qualifier: MONDO:0007739
      subject_extension: normal glia
    - subject: Striatal transplantation
      predicate: RESCUES
      object: hyperexcitability of striatal neurons
      qualifier: MONDO:0007739
      subject_extension: normal glia
    - subject: Striatal transplantation
      predicate: RESTORES
      object: disturbed interstitial potassium homeostasis
      qualifier: MONDO:0007739
      subject_extension: normal glia
named_entities:
  - id: MONDO:0007739
    label: Huntington disease
  - id: HP:0002529
    label: neuronal loss
  - id: HP:0010535
    label: sleep disordered breathing
  - id: MAXO:0000010
    label: cognitive behavioural therapy
  - id: HP:0004305
    label: involuntary movements
  - id: MONDO:0005395
    label: Movement disorders
  - id: MAXO:0001000
    label: Functional MRI (fMRI)
  - id: MAXO:0009070
    label: Single-photon emission computed tomography (SPECT)
  - id: HP:0002487
    label: Hyperkinetic movements
  - id: HP:0001332
    label: Dystonic movements
  - id: HP:0100022
    label: Movement disorders
  - id: MAXO:0000127
    label: Genetic testing
  - id: MAXO:0000079
    label: Genetic counseling
  - id: HP:0025464
    label: oxidative stress
  - id: CHEBI:16908
    label: NADH
  - id: CHEBI:30879
    label: Alcohol
  - id: CHEBI:23888
    label: Drugs
  - id: MAXO:0000882
    label: Behavioral interventions
  - id: HP:0100543
    label: cognitive deficits
  - id: CHEBI:3723
    label: citalopram
  - id: HP:0002340
    label: Caudate atrophy
  - id: CHEBI:566274
    label: Malondialdehyde (MDA)
  - id: CHEBI:149681
    label: Catalase (CAT)
  - id: CHEBI:73860
    label: Glutathione reductase (GR)
  - id: CHEBI:16856
    label: Reduced glutathione (GSH)
  - id: MONDO:0005301
    label: Multiple Sclerosis
  - id: CHEBI:76720
    label: Antisense oligonucleotides
  - id: HP:0002333
    label: motor deterioration
  - id: HP:0002072
    label: Chorea
  - id: HP:0040141
    label: Tardive dyskinesia
  - id: HP:0100033
    label: Tics
  - id: CHEBI:9467
    label: Tetrabenazine
  - id: MONDO:0007661
    label: Tourette syndrome
  - id: HP:0002500
    label: white matter abnormalities
  - id: MAXO:0000487
    label: clinical assessments
  - id: MAXO:0000387
    label: muscle biopsy
  - id: HP:0012531
    label: pain
  - id: MAXO:0000610
    label: enzyme-linked immunosorbent assay
  - id: MAXO:0000011
    label: Physical therapy
  - id: MONDO:0024237
    label: Hereditary neurodegenerative diseases
  - id: MONDO:0005559
    label: Neurodegenerative diseases
  - id: HP:0000741
    label: apathy
  - id: HP:0000716
    label: depression
  - id: CHEBI:46245
    label: coenzyme Q10
  - id: MONDO:0005180
    label: Parkinson disease
  - id: HP:0001824
    label: Weight loss
  - id: MONDO:0005314
    label: Relapsing-remitting multiple sclerosis (RRMS)
  - id: CHEBI:134738
    label: Laquinimod
  - id: HP:0011227
    label: elevated CRP
  - id: HP:0001288
    label: gait abnormalities
  - id: CHEBI:17488
    label: scopoletin
  - id: CHEBI:16348
    label: 3-nitropropionic acid (3-NP)
  - id: CHEBI:35255
    label: chloroform
  - id: CHEBI:27750
    label: ethyl acetate
  - id: CHEBI:28885
    label: n-butanol
  - id: MAXO:0009003
    label: Preimplantation genetic diagnosis (PGD)
  - id: MAXO:0000003
    label: Diagnostic testing
  - id: MONDO:0007915
    label: Systemic Lupus Erythematosus (SLE) Chorea
  - id: MAXO:0000427
    label: Brain MRI
  - id: MAXO:0001298
    label: Therapy
  - id: HP:0000739
    label: anxiety
  - id: MAXO:0009088
    label: Stimulated Raman Scattering (SRS) microscopy
  - id: CHEBI:18254
    label: Ribonucleosides
  - id: CHEBI:23636
    label: Deoxyribonucleosides
  - id: CHEBI:33709
    label: Amino acids
  - id: CHEBI:35366
    label: Fatty acids
  - id: CHEBI:15354
    label: Choline
  - id: CHEBI:17234
    label: Glucose
  - id: CHEBI:16113
    label: Cholesterol
  - id: CHEBI:22339
    label: Alkynes
  - id: CHEBI:33324
    label: <Stimulated Raman Scattering (SRS) microscopy>
  - id: HP:0002344
    label: Progressive neurodegeneration
  - id: CHEBI:48607
    label: lithium chloride
